Clinical Microbiology and Infection

Papers
(The H4-Index of Clinical Microbiology and Infection is 84. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis994
COVID-19, SARS and MERS: are they closely related?763
Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study583
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review566
Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis507
Follow-up of adults with noncritical COVID-19 two months after symptom onset495
Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting467
Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study463
Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China431
Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay420
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society 353
Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19282
Novel SARS-CoV-2 variants: the pandemics within the pandemic271
SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis263
COVID-19 pandemic—a focused review for clinicians262
Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis260
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults254
BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel248
COVID-19: don't neglect antimicrobial stewardship principles!246
Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study235
A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India233
Female gender is associated with long COVID syndrome: a prospective cohort study230
Machine learning for clinical decision support in infectious diseases: a narrative review of current applications228
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors223
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain217
Impact of COVID-19 on maternal and neonatal outcomes: a systematic review and meta-analysis209
Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres203
Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients202
Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients196
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis193
Viable SARS-CoV-2 in various specimens from COVID-19 patients178
Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study169
Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans166
Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study165
Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital158
Large-scale implementation of pooled RNA extraction and RT-PCR for SARS-CoV-2 detection149
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study144
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis140
Recommendations for antibacterial therapy in adults with COVID-19 – an evidence based guideline139
Pathogenesis and management of fracture-related infection135
Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection133
Validation of a commercially available SARS-CoV-2 serological immunoassay132
Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity129
Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological results127
2020 list of human papillomavirus assays suitable for primary cervical cancer screening124
Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology123
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1123
Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review122
Post–COVID-19 chronic symptoms: a postinfectious entity?118
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST)117
Outbreak of Candida auris infection in a COVID-19 hospital in Mexico116
Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs116
Severe acute respiratory syndrome coronavirus 2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit115
Anosmia in COVID-19 patients113
Machine learning for microbial identification and antimicrobial susceptibility testing on MALDI-TOF mass spectra: a systematic review106
Ibuprofen use and clinical outcomes in COVID-19 patients103
ESCMID COVID-19 living guidelines: drug treatment and clinical management103
Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients102
Oral amoxicillin and amoxicillin–clavulanic acid: properties, indications and usage102
Understanding the role of bacterial and fungal infection in COVID-19101
Detection and infectivity potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) environmental contamination in isolation units and quarantine facilities98
A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients98
Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort study97
Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan96
Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study96
The role of asymptomatic and pre-symptomatic infection in SARS-CoV-2 transmission—a living systematic review95
How to interpret and use COVID-19 serology and immunology tests95
The interface between COVID-19 and bacterial healthcare-associated infections94
Stigma at the time of the COVID-19 pandemic93
Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status93
Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019—a multi-centre observational study92
Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort92
Association of COVID-19 with pregnancy outcomes in health-care workers and general women92
Clinical evaluation of serological IgG antibody response on the Abbott Architect for established SARS-CoV-2 infection91
Current landscape in the discovery of novel antibacterial agents89
Global prevalence of latent toxoplasmosis in pregnant women: a systematic review and meta-analysis89
Clostridium difficile and One Health88
Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort88
Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study88
Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary—the HUN-VE study87
Risk factors for chronic biofilm-related infection associated with implanted medical devices85
Commercially available molecular tests for human papillomaviruses: a global overview84
Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in Italy84
How do I manage nocardiosis?84
0.045783042907715